NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text

Search Results

5342. Anthrax: developing drugs for prophylaxis of inhalational anthrax

5343. Complicated intra-abdominal infections: developing drugs for treatment

5344. Complicated urinary tract infections: developing drugs for treatment

5345. Medical product communications that are consistent with the FDA-required labeling: questions and answers

5346. Drug and device manufacturer communications with payors, formulary committees, and similar entities: questions and answers : guidance for industry and review staff

5347. Logical observation identifiers names and codes for in vitro diagnostic tests: guidance for industry and Food and Drug Administration staff

5348. S9 nonclinical evaluation for anticancer pharmaceuticals: questions and answers

5349. Assessing user fees under the biosimilar user fee amendments of 2017